⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13921427 | 0.76 | — | — | |
| SCHEMBL13921429 | 0.69 | KCNH2 (0.33) | — | |
| SCHEMBL14749855 | 0.68 | KCNH2 (0.33) | — | |
| SCHEMBL23332248 | 0.66 | — | — | |
| SCHEMBL14749872 | 0.63 | — | — | |
| SCHEMBL25790737 | 0.61 | CRHBP (0.39) | — | |
| SCHEMBL23344774 | 0.59 | KCNH2 (0.33) | — | |
| SCHEMBL28788184 | 0.56 | — | — | |
| SCHEMBL26778016 | 0.56 | GRIN2D (0.31) | — | |
| SCHEMBL12105024 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10428070-B2 | Hepatitis B antiviral agents | ENANTA PHARMACEUTICALS, INC. (US) | 2019-10-01 | — | — | US | disclosed |
| US-20190177320-A1 | HEPATITIS B ANTIVIRAL AGENTS | ENANTA PHARMACEUTICALS, INC. | 2019-06-13 | — | — | US | disclosed |